
Microanalysis sp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Microanalysis develops analytical and medical technologies, including a chemical dialysate analyzer designed to enable personalized dialysis treatment. Its work also covers microfluidics, lab-on-chip and lab-on-paper systems, measurement device design, analytical process automation, prototyping, and scientific and technological consulting.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 518 days for 2023).
- 2025not filed
- 202408/01/2026
- 202315/12/2025
- 202212/09/2024
- 202124/01/2023
- 202020/01/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
News

Certificates

Innovative device for hemodialysis monitoring developed at the University of Warsaw
Breakthrough in hemodialysis monitoring

Invention from the University of Warsaw to improve safety of dialysis patients
Distinction in the University of Warsaw Entrepreneur of the Year competition
Increasing safety in hemodialysis treatment
Industry
Offer
- Chemical and analytical testing
- Measurement device design
- Device prototyping
- Scientific and technological consulting
- Development of analytical methods
- Biomaterial design
Websites
The site is available in: Polish and English.
- microanalysis.plStrona główna – Microanalysis Sp. z o. o. – innowacyjny chemiczny analizator dializatu umożliwiający personalizację zabiegu dializyWordPress 5.8Google AnalyticsGoogle Tag ManagerCloudflareApache
Authorized Representatives
Manner of representation
The management board of the company consists of 2 members; two members of the management board acting jointly are authorised to submit declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 105 | $1,418.15 | 51.2195% | |
Michał Andrzej Michalec age 37 | 45 | $607.78 | 21.9512% |
Łukasz Tymecki age 49 | 45 | $607.78 | 21.9512% |
| 10 | $135.06 | 4.878% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2021-04-15.
40 1090 2590 0000 0001 4762 8718
80 1090 2590 0000 0001 4762 8774
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $1,527,521.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 7, 2020 | Aid for research and development projects: experimental development | $933.1K$933,074 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 7, 2020 | Aid for research and development projects: industrial research | $428.4K$428,420 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 7, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $156.9K$156,931 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-12-01 | Innovative chemical dialysate analyser enabling personalised dialysis treatment | $1.5M$1,518,426 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| EMAG Design sp. z o.o. | $6,357.63 | emag-design.pl | ||
| Purevidence sp. z o.o. | $4,997.49 | purevidence.pl | ||
| Centrum Badawczo Rozwojowe Pan Inqban sp. z o.o. | $4,453.11 | cbrpaninqban.pl | ||
| CBR Me sp. z o.o. | $3,684.91 | cbr-me.pl | ||
| Narmox sp. z o.o. | $1,946.87 | narmox.com | ||
| Ekspertis Budownictwo sp. z o.o. | $1,522.00 | ekspertis.eu | ||
| NIOH Nioh sp. z o.o. | $1,429.22 | niohnioh.com | ||
| UIF S.A. | $1,284.60 | unipress.waw.pl | ||
| Krajowe Centrum Nowych Technologii sp. z o.o. | $1,255.65 | kcnt.pl | ||
| WTT Innowacje sp. z o.o. | $1,143.00 | wttinnowacje.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-09-16 | Address change (Ul. Żwirki I Wigury 101, 02-089, Warszawa → Ul. Barska 7/9/9, 02-315, Warszawa) | |
| 2021-06-24 | Share capital increase (5,000.00 PLN → 10,250.00 PLN) | |
| 2018-12-13 | Entered in the register |
FAQ
Last updated: 2026-04-10